Consonance Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,005,218
Closed -$29.7M 41
2020
Q3
$29.7M Buy
+2,005,218
New +$29.7M 3.62% 14